Neoadjuvant Treatment in Pancreatic Cancer

Neoadjuvant Treatment in Pancreatic Cancer

Thanks to the development of modern chemotherapeutic regimens, survival after surgery for pancreatic ductal adenocarcinoma (PDAC) has improved and pancreatologists worldwide agree that the treatment of PDAC demands a multidisciplinary approach. Neoadjuvant treatment (NAT) plays a major role in the t...

Full description

Bibliographic Details
Main Authors: Atsushi Oba, Felix Ho, Quoc Riccardo Bao, Mohammed H. Al-Musawi, Richard D. Schulick, Marco Del Chiaro
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Oncology
Subjects:
neoadjuvant therapy
neoadjuvant chemotherapy
neoadjuvant chemoradiotherapy
borderline resectable
locally advanced
FOLFIRINOX
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00245/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.00245/full

Similar Items